220 related articles for article (PubMed ID: 22840683)
41. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
Chan YC; Cheng SW; Ting AC; Cheung GC
J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
[TBL] [Abstract][Full Text] [Related]
42. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
43. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients.
Schulte KL; Kralj I; Gissler HM; Bagnaschino LA; Buschmann I; Pernès JM; Haage P; Goverde P; Beregi JP; Válka M; Boudny J; Geibel T; Velkoborsky M; Zähringer M; Paetzel C; Fanelli F; Müller-Hülsbeck S; Zeller T; Langhoff R
J Endovasc Ther; 2012 Dec; 19(6):774-84. PubMed ID: 23210876
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness of Zilver PTX eluting stent in TASC C/D lesions and restenosis.
Leopardi M; Houbballah R; Becquemin JP
J Cardiovasc Surg (Torino); 2014 Apr; 55(2):229-34. PubMed ID: 24670831
[TBL] [Abstract][Full Text] [Related]
45. Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions.
Dohi T; Iida O; Soga Y; Hirano K; Suzuki K; Takahara M; Uematsu M; Nanto S
J Vasc Surg; 2014 Apr; 59(4):1009-1015.e1. PubMed ID: 24360237
[TBL] [Abstract][Full Text] [Related]
46. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses.
Iida O; Uematsu M; Soga Y; Hirano K; Suzuki K; Yokoi H; Muramatsu T; Inoue N; Nanto S; Nagata S
Catheter Cardiovasc Interv; 2011 Oct; 78(4):611-7. PubMed ID: 21805562
[TBL] [Abstract][Full Text] [Related]
47. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
Grenville JL; Tan KT; Moshonov H; Rajan DK
Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
[TBL] [Abstract][Full Text] [Related]
48. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty.
Gray BH; Sullivan TM; Childs MB; Young JR; Olin JW
J Invasive Cardiol; 2004 Jan; 16 Suppl A():3A-9A; discussion 9A-11A. PubMed ID: 23573598
[TBL] [Abstract][Full Text] [Related]
49. Early experience with the EntrustTM delivery system for stent treatment of the lower extremities' arteries via transbrachial approach.
Stavroulakis K; Bisdas T; Torsello G; Bosiers MJ; Schwindt A
J Cardiovasc Surg (Torino); 2014 Aug; 55(4):483-8. PubMed ID: 24975735
[TBL] [Abstract][Full Text] [Related]
50. Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study.
Trabattoni D; Agrifoglio M; Cappai A; Bartorelli AL
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):678-82. PubMed ID: 20216226
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study.
Werner M; Micari A; Cioppa A; Vadalà G; Schmidt A; Sievert H; Rubino P; Angelini A; Scheinert D; Biamino G
JACC Cardiovasc Interv; 2014 Mar; 7(3):305-12. PubMed ID: 24529932
[TBL] [Abstract][Full Text] [Related]
52. Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol.
Soga Y; Iida O; Hirano K; Suzuki K; Yokoi H; Nobuyoshi M
Catheter Cardiovasc Interv; 2012 Mar; 79(4):541-8. PubMed ID: 21805619
[TBL] [Abstract][Full Text] [Related]
53. Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions.
Burket MW; Brodmann M; Metzger C; Tan K; Jaff MR
J Vasc Interv Radiol; 2016 Nov; 27(11):1650-1656.e1. PubMed ID: 27542591
[TBL] [Abstract][Full Text] [Related]
54. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
[TBL] [Abstract][Full Text] [Related]
55. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease.
Lammer J; Bosiers M; Zeller T; Schillinger M; Boone E; Zaugg MJ; Verta P; Peng L; Gao X; Schwartz LB
J Vasc Surg; 2011 Aug; 54(2):394-401. PubMed ID: 21658885
[TBL] [Abstract][Full Text] [Related]
56. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
[TBL] [Abstract][Full Text] [Related]
57. Crushed stent with acute occlusion in superficial femoral artery after enhanced external counterpulsation.
Suh Y; Ko YG; Lee SH; Kim MD; Choi D
JACC Cardiovasc Interv; 2014 Oct; 7(10):e141-2. PubMed ID: 25240552
[No Abstract] [Full Text] [Related]
58. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
[TBL] [Abstract][Full Text] [Related]
59. Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
Angle JF; Gasparetto A; Yokoi H; Jaff MR; Popma JJ; Piegari GN; Iyengar SS; Ohki T
J Vasc Interv Radiol; 2020 Jun; 31(6):978-985. PubMed ID: 32414572
[TBL] [Abstract][Full Text] [Related]
60. Initial clinical experience with the Protégé EverFlex long self-expanding nitinol stent in the superficial femoral artery.
Ruef J; Hofmann M; Haase J
J Interv Cardiol; 2006 Dec; 19(6):544-6. PubMed ID: 17107370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
